4.6 Article

Targeting α-synuclein post-translational modifications in Parkinson's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties

Sydney E. Dent et al.

Summary: In this study, we found that both alpha-synuclein (aSyn) and its phosphorylated form (pSyn) can bind DNA in a DNA length-dependent manner, but without specificity for DNA sequence. We also observed that the phosphorylation of serine-129 reduces the ability of aSyn to bind and bend DNA. These findings suggest that the ability of aSyn to interact with DNA and modulate DNA metabolism may be regulated by phosphorylation.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body

Shiori Awa et al.

Summary: This study investigated the early phase of phosphorylated alpha-synuclein accumulation by injecting alpha-synuclein fibrils into the brains of wild-type mice. The results showed that phosphorylated alpha-synuclein appeared within a few days after injection, initially in presynaptic regions and subsequently extending its localization to axons and cell bodies.

SCIENTIFIC REPORTS (2022)

Article Biology

The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization

Azad Farzadfard et al.

Summary: Farzadfard et al. conducted a comprehensive analysis on a range of C-terminal truncations of aSN, revealing the importance of high C-terminus charge for decreased fibrillation rates. Truncated aSN showed decreased ability to form oligomers, disrupt synthetic vesicles, and exhibit cell toxicity, while still promoting or inhibiting aggregation through intramolecular interactions. Truncation of the C-terminal domain not only increased fibrillation tendency but also suppressed toxic oligomer formation, with changes in electrostatic potential serving as a double-edged safety guard.

COMMUNICATIONS BIOLOGY (2022)

Article Biochemistry & Molecular Biology

O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate forTau and?-Synuclein Proteinopathies

Bruno Permanne et al.

Summary: Neurodegenerative proteinopathies are characterized by the intracellular formation of insoluble and toxic protein aggregates in the brain that are closely linked to disease progression. In this study, the inhibition of OGA was found to prevent the aggregation and toxicity of tau and alpha-synuclein, suggesting its potential as a therapeutic approach. The novel OGA inhibitor ASN90 demonstrated promising preclinical results, preventing tau pathology, improving motor behavior and survival, and reducing astrogliosis in mouse models.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

Azad Farzadfard et al.

Summary: This study reveals the inhibitory effect of glycation on alpha-synuclein fibril formation and provides insights into its molecular mechanism. Glycation primarily affects the elongation of alpha-synuclein and has a modest impact on oligomerization.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity

Simona S. Ghanem et al.

Summary: The phosphorylation of alpha-synuclein at serine 129 inhibits fibril formation and appears to have a protective role in the aggregation process, which has implications for understanding the pathobiology of Lewy body disease.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Neurosciences

Serine/Threonine Protein Phosphatase 2A Regulates the Transport of Axonal Mitochondria

Keunjung Heo et al.

Summary: Microtubule-based transport is crucial for neuronal health by delivering mitochondria to distant regions of neurons. In this study, two compounds, indirubin and cantharidin, were identified to enhance mitochondrial motility in rat cortical neurons through a high-throughput screening. Further experiments demonstrated the importance of protein phosphatase 2A (PP2A) as a regulator of mitochondrial motility and suggested that cantharidin's effect may be mediated by PP2A.

FRONTIERS IN CELLULAR NEUROSCIENCE (2022)

Article Multidisciplinary Sciences

Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein

Takashi Ohgita et al.

Summary: The A53T mutation and C-terminal truncation enhance the aggregation of α-synuclein by reducing the unfavorable activation enthalpy of nucleation, and the truncation further triggers the autocatalytic fibril elongation on the fibril surfaces.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson's Disease and Multiple System Atrophy

Berkiye Sonustun et al.

Summary: The predominant post-translational modifications of alpha-synuclein in the pathological process of idiopathic Parkinson's disease and multiple system atrophy were found to be phosphorylation and nitration, with phosphorylated alpha-synuclein being the earliest and most abundant form. These findings may have implications for the development of novel biomarkers and therapeutic approaches.
Article Geriatrics & Gerontology

Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease

Chao-Wen Lin et al.

Summary: The levels of alpha-synuclein and NfL in tears as well as retinal microvascular densities are associated with the risk and progression of Parkinson's disease.

GEROSCIENCE (2022)

Article Neurosciences

Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes

Ana Chegao et al.

Summary: This study found that MGO-induced glycation accelerates PD-like sensorimotor and cognitive alterations and increases the accumulation of α-synuclein in the brain. In addition, the study also found that MGO mainly affects glutamatergic signaling in the midbrain, which may be associated with PD and dopaminergic pathways.

NPJ PARKINSONS DISEASE (2022)

Article Cell Biology

Rapid macropinocytic transfer of ?-synuclein to lysosomes

Armin Bayati et al.

Summary: This study reveals the rapid internalization and lysosomal targeting mechanism of alpha-synuclein fibrils in cells. The fibrils are internalized through a non-classical endocytic pathway and a portion of them are transferred to neighboring cells along with exosomes. These findings provide insights into the cell-to-cell propagation of alpha-synuclein fibrils.

CELL REPORTS (2022)

Article Multidisciplinary Sciences

Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models

Ying Xue Xie et al.

Summary: This study demonstrates that pathogenic aggregates of alpha-Synuclein (alpha Syn) generated by neurons accumulate within neuronal lysosomes and are released via SNARE-dependent lysosomal exocytosis. These findings provide important insights into the release mechanism of aggregates and the spread of pathology in synucleinopathies.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils

Omid Tavassoly et al.

Summary: The hallmark of Parkinson's disease is the formation of Lewy bodies in the brain, which can be inhibited by a pharmacological agent Thiamet-G through blocking the cellular uptake of α-syn fibrils. This mechanism may offer a potential disease-modifying approach for treating PD.

FEBS JOURNAL (2021)

Article Chemistry, Physical

Acetylation Rather than H50Q Mutation Impacts the Kinetics of Cu(II) Binding to α-Synuclein

Xiangyu Teng et al.

Summary: The interaction between alpha-Synuclein and Cu2+ plays a role in brain copper homeostasis, potentially affecting the progression of Parkinson's disease. While the H50Q mutation does not impact Cu2+ binding to WT-alpha Syn, NAc-alpha Syn shows significantly weaker Cu2+ binding affinity. Cu2+ coordination mode to NAc-alpha Syn has been proposed based on EPR spectrum.

CHEMPHYSCHEM (2021)

Article Neurosciences

Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein

Lilit Gabrielyan et al.

Summary: The study found that male Thy1-alpha-syn mice exhibited more severe behavioral impairments compared to their female counterparts, as well as wild type mice. The differences in behavior were related to higher brain levels of human alpha-syn, rather than sex differences in the altered brain immunoreactivity patterns of alpha-syn and pS129 alpha-syn.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Neurosciences

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders

Vasilios C. Constantinides et al.

Summary: Studies on CSF alpha-syn species in patients with diverse underlying pathologies revealed that PD patients exhibited higher pS129-alpha-syn/alpha-syn ratios compared to FTD, while MSA patients had lower alpha-syn levels compared to CBD in movement disorders. Patients with synucleinopathy showed lower t-alpha-syn levels and higher pS129-/t-alpha-syn ratios compared to patients with tauopathies. No significant alpha-syn species alterations were observed in non-synucleinopathies.

BRAIN SCIENCES (2021)

Article Neurosciences

Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking

Cristina Roman-Vendrell et al.

Summary: Alpha-synuclein accumulates in neurodegenerative diseases, affecting synaptic function and leading to motor, cognitive, and autonomic dysfunction. Different molecular species of alpha-synuclein result in distinct trafficking defects at synapses, with multimeric alpha-synuclein causing intracellular vesicle trafficking impairment.

FRONTIERS IN NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type α-synuclein

Yunpeng Sun et al.

Summary: The study demonstrates that the G51D mutation induces a distinct fibril strain of alpha-syn in vitro, with the corresponding structure determined by cryo-EM.

NATURE COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease

Songzhe He et al.

Summary: This review summarizes the structure, physiological function, and effects of post-translational modifications on alpha-syn aggregation, which may elucidate mechanisms for Parkinson's disease pathogenesis and lay a theoretical foundation for clinical treatment.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Neurosciences

Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2

Kazunori Sano et al.

Summary: The phosphorylation of alpha synuclein at Y136 in the Lewy body dementia brain is mediated by the unexpected kinase activity of CK2. CK2 can promote aggregate formation of r-alpha Syn with phosphorylation at S129 and Y136, while its inhibition attenuates the formation of aggregates with S129 phosphorylation and unexpectedly increases phosphorylation at Y136.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Neurosciences

Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's disease

Elena Vacchi et al.

Summary: The study evaluated the diagnostic and prognostic capacity of alpha Syn oligomers in PD through skin biopsies. The findings showed that alpha Syn-PLA had the highest diagnostic accuracy, while small fiber neuropathy was detected in PD and MSA. Additionally, skin denervation, not pathological alpha Syn, was identified as a potential progression marker for PD.

NPJ PARKINSONS DISEASE (2021)

Article Biochemistry & Molecular Biology

α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson's Disease

Kathrine Stokholm et al.

Summary: The overexpression of alpha-synuclein leads to dopaminergic degeneration, resulting in compensatory increases in D2/3 receptor binding and immune activation, recapitulating many of the pathological characteristics of Parkinson's disease.

BIOMEDICINES (2021)

Article Cell Biology

Phosphorylated α-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson's disease through TLR2/NF-κB pathway

Li Sun et al.

Summary: The study demonstrates that in PD mice models, p-alpha-syn can accumulate in SCs of sciatic nerves, resulting in damage to SCs and axons. It is confirmed that the TLR2/NF-κB pathway plays a role in PD peripheral neuropathy, and treatment with CU-CPT22 can improve motor and sensory functions associated with the condition.

CELL DEATH DISCOVERY (2021)

Article Clinical Neurology

Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort

Nour K. Majbour et al.

Summary: This study investigated CSF biomarkers levels in newly diagnosed Parkinson's disease patients, finding that CSF oligomeric alpha-synuclein increased with disease severity and reflected PD motor trajectories.

MOVEMENT DISORDERS (2021)

Article Neurosciences

In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129

Leah J. Weston et al.

Summary: Abnormal aggregation of α-synuclein is a key feature of neurodegenerative diseases, but the mechanisms behind this aggregation remain unclear. Using a zebrafish model, researchers were able to express and measure various forms of human α-synuclein and found distinct pools of the protein with different mobility, indicating different subpopulations of aggregated and non-aggregated protein. Phosphorylation at serine-129 does not significantly affect the mobility of α-synuclein, suggesting that it alone does not promote protein aggregation.

NEUROBIOLOGY OF DISEASE (2021)

Review Cell Biology

DNA Double-Strand Breaks: A Double-Edged Sword for Trypanosomatids

Marcelo Santos da Silva

Summary: This article discusses the unique dependence of trypanosomatids on DSBs for important events such as antigenic variation, genetic exchange, and genomic changes, as well as how they balance the benefits and challenges caused by DSBs through homologous recombination.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Clinical Neurology

Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit

Alessandro Tozzi et al.

Summary: The study identified that alpha-synuclein disrupts dopamine system and striatal synaptic plasticity in early stages of Parkinson's disease. Subchronic treatment with L-DOPA was able to rescue alpha-synuclein-induced alterations, showing the critical role of dysfunctional dopamine system in disease progression.
Article Biochemistry & Molecular Biology

Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice

Rossana Di Martino et al.

Summary: The study investigated the molecular mechanisms leading to mitochondrial dysfunction and found that in A53T mice, mitochondrial dysfunction occurs early in the midbrain and later in the striatum due to impaired NCX3 protein expression. Early mitochondrial dysfunction in the midbrain triggers neuroinflammation later in the striatum, contributing to the progression of Parkinson's disease in aging mice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Clinical Neurology

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders

Isabel Schulz et al.

Summary: Objective diagnostic biomarkers are needed to support a clinical diagnosis of neurodegenerative disorders, with various markers being analyzed in serum and/or cerebrospinal fluid for alpha-synuclein-related disorders. Levels of most markers tested significantly differed between disease groups and healthy controls, with CSF NfL levels best discriminating between Parkinson's disease and multiple system atrophy.

MOVEMENT DISORDERS (2021)

Article Multidisciplinary Sciences

The N terminus of α-synuclein dictates fibril formation

Ryan P. McGlinchey et al.

Summary: The study demonstrates that C-terminal truncations can accelerate the aggregation of alpha-synuclein, while the role of N-terminal truncations remains unclear. The research found that N-terminal truncations modulated the aggregation kinetics and fibril morphologies of alpha-synuclein.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Pharmacology & Pharmacy

Histone post-translational modifications as potential therapeutic targets for pain management

Jose Torres-Perez et al.

Summary: The article discusses the role of histone post-translational modifications (PTMs) in influencing nociception and pain phenotypes following tissue injury, and the opportunities and challenges of targeting histone PTMs to relieve pain in clinically relevant tissue injuries.

TRENDS IN PHARMACOLOGICAL SCIENCES (2021)

Article Cell Biology

Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion

Qilin Tang et al.

Summary: The study reveals that alpha-Syn impairs autophagy turnover by reducing the fusion of autophagosomes with lysosomes, leading to a decrease in the formation of autolysosomes. Additionally, alpha-Syn increases the number of extracellular vesicles and the abundance of autophagy-associated proteins in these vesicles. Mechanistically, alpha-Syn decreases the abundance of the v-SNARE protein SNAP29, impacting autophagolysosome fusion and ultimately influencing DA neuronal cell death.

CELL DEATH & DISEASE (2021)

Article Cell Biology

Altered conformation of a-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease

Luis Fonseca-Ornelas et al.

Summary: The study shows that the misfolding of alpha-synuclein is linked to the pathogenesis of Parkinson's disease, leading to abnormalities in Ca2+-dependent vesicle exocytosis and synaptic vesicle ultrastructure. The altered conformation of alpha-synuclein may be an early cause of synaptotoxicity in synucleinopathies.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes

Aysegul Dilsizoglu Senol et al.

Summary: This research indicates that α-syn fibrils affect the morphology and function of lysosomes in neuronal cells, facilitating their transmission to recipient cells through tunneling nanotubes. Lysosomes play a crucial role in the seeding and propagation of disease pathology by acting as a Trojan horse, as revealed by super-resolution and electron microscopy.

PLOS BIOLOGY (2021)

Article Neurosciences

Low-Expressing Synucleinopathy Mouse Models Based on Oligomer-Forming Mutations and C-Terminal Truncation of α-Synuclein

Ana Martinez Hernandez et al.

Summary: The article introduces two mouse models of synucleinopathies based on mutations in alpha-synuclein that do not overexpress the mutant protein, with a triple alanine to proline mutation and a C-terminal truncation. These models can be used to study the pathology associated with alpha-synuclein variants.

FRONTIERS IN NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies

Ilaria Poggiolini et al.

Summary: The study revealed that C-alpha Syn species can distinguish between PD and DLB, suggesting that the diversity of alpha Syn species in these synucleinopathies may play a role in disease progression.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation

Zhaohui Liang et al.

Summary: A SUMO1(15-55) peptide inhibitor has been developed to suppress alpha-synuclein aggregation and reduce alpha-synuclein-induced cytotoxicity in cell-based and Drosophila disease models. Molecular modeling and binding studies revealed the mode of interaction between the inhibitor and alpha-synuclein, showing binding via SUMO-interacting motifs and a hydrophobic binding groove.

CELL CHEMICAL BIOLOGY (2021)

Review Clinical Neurology

Parkinson disease

R. Balestrino et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Article Clinical Neurology

CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls

Linda P. Oosterveld et al.

MOVEMENT DISORDERS (2020)

Review Biochemistry & Molecular Biology

Molecular mechanisms in SUMO conjugation

Nathalia Varejao et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2020)

Review Biochemistry & Molecular Biology

Role of Post-translational Modifications in Alzheimer's Disease

Madhu Ramesh et al.

CHEMBIOCHEM (2020)

Review Cardiac & Cardiovascular Systems

The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation

Jinning Gao et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)

Article Chemistry, Organic

Ubiquitination Can Change the Structure of the α-Synuclein Amyloid Fiber in a Site Selective Fashion

Stuart P. Moon et al.

JOURNAL OF ORGANIC CHEMISTRY (2020)

Article Cell Biology

Alpha-synuclein fragments trigger distinct aggregation pathways

Tasnim Chakroun et al.

CELL DEATH & DISEASE (2020)

Article Clinical Neurology

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

Chun-Wei Chang et al.

FRONTIERS IN NEUROLOGY (2020)

Article Neurosciences

N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity

Rodrigo Vinueza-Gavilanes et al.

NEUROBIOLOGY OF DISEASE (2020)

Article Neurosciences

Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein

Yuan Guan et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Article Multidisciplinary Sciences

Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity

Amberley D. Stephens et al.

NATURE COMMUNICATIONS (2020)

Review Geriatrics & Gerontology

SUMOylation in alpha-Synuclein Homeostasis and Pathology

Mor Savyon et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Review Chemistry, Multidisciplinary

Deciphering protein post-translational modifications using chemical biology tools

Anne C. Conibear

NATURE REVIEWS CHEMISTRY (2020)

Review Neurosciences

New Insights Into Drug Discovery Targeting Tau Protein

Yoshiyuki Soeda et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein

Raquel Pinho et al.

HUMAN MOLECULAR GENETICS (2019)

Article Multidisciplinary Sciences

Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution

Xi Li et al.

SCIENTIFIC REPORTS (2019)

Article Neurosciences

Alpha-Synuclein Continues to Enhance SNARE-Dependent Vesicle Docking at Exorbitant Concentrations

Brenden J. D. Hawk et al.

FRONTIERS IN NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

Glycation of α-synuclein amplifies the binding with glyceraldehyde-3-phosphate dehydrogenase

Pavel Semenyuk et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)

Review Cell Biology

Post-translational regulation of ubiquitin signaling

Lei Song et al.

JOURNAL OF CELL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

Effects of alpha-synuclein post-translational modifications on metal binding

Nazareno Gonzalez et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Article Neurosciences

Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease

Chen Tian et al.

TRANSLATIONAL NEURODEGENERATION (2019)

Article Cell Biology

A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology

Juan A. Gerez et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Multidisciplinary Sciences

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders

Allison J. Schaser et al.

SCIENTIFIC REPORTS (2019)

Article Multidisciplinary Sciences

Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein

Katsuya Araki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Cell Biology

Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons

Goutham K. Ganjam et al.

CELL DEATH & DISEASE (2019)

Article Biochemistry & Molecular Biology

Modification by glyceraldehyde-3-phosphate prevents amyloid transformation of alpha-synuclein

Kseniya Barinova et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)

Article Multidisciplinary Sciences

α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease

Paul M. Levine et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Neurosciences

Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates

Shamini Vijayakumaran et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2019)

Review Cell Biology

The many substrates and functions of NEDD4-1

Xi Huang et al.

CELL DEATH & DISEASE (2019)

Article Medicine, Research & Experimental

Cell Biology and Pathophysiology of α-Synuclein

Jacqueline Burre et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Article Biochemistry & Molecular Biology

Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation

Cristine Betzer et al.

EMBO REPORTS (2018)

Article Biochemistry & Molecular Biology

Refolding of helical soluble α-synuclein through transient interaction with lipid interfaces

Matteo Rovere et al.

FEBS LETTERS (2018)

Article Clinical Neurology

Phosphorylated alpha-Synuclein in the Retina Is a Biomarker of Parkinson's Disease Pathology Severity

Isabel Ortuno-Lizaran et al.

MOVEMENT DISORDERS (2018)

Article Multidisciplinary Sciences

α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies

Iryna Prots et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease

Marthe H. R. Ludtmann et al.

NATURE COMMUNICATIONS (2018)

Article Chemistry, Multidisciplinary

Alpha-Synuclein Modulates the Physical Properties of DNA

Kai Jiang et al.

CHEMISTRY-A EUROPEAN JOURNAL (2018)

Review Neurosciences

Levodopa in Parkinson's Disease: Current Status and Future Developments

Nicola Tambasco et al.

CURRENT NEUROPHARMACOLOGY (2018)

Review Biochemistry & Molecular Biology

Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum

Thaiany Quevedo Melo et al.

NEUROCHEMICAL RESEARCH (2018)

Article Pharmacology & Pharmacy

Endoplasmic reticulum stress and apoptosis induced by manganese trigger alpha-synuclein accumulation

Hyonok Yoon et al.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2018)

Review Medicine, Research & Experimental

The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy

Fatima Ardito et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)

Article Clinical Neurology

Epidemiology of Parkinson's disease

Ole-Bjorn Tysnes et al.

JOURNAL OF NEURAL TRANSMISSION (2017)

Review Cell Biology

Protein O-GlcNAcylation: emerging mechanisms and functions

Xiaoyong Yang et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)

Review Neurosciences

Non-motor features of Parkinson disease

Anthony H. V. Schapira et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Article Multidisciplinary Sciences

SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation

Ruth Rott et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease

Jenny-Ann Phan et al.

SCIENTIFIC REPORTS (2017)

Article Neurosciences

Alzheimer's Disease and the Amyloid-β Peptide

M. Paul Murphy et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Multidisciplinary Sciences

Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease

Hugo Vicente Miranda et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations

Shruti Sahay et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2017)

Article Biochemistry & Molecular Biology

Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization

Filsy Samuel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes

Saida Abounit et al.

EMBO JOURNAL (2016)

Review Biochemistry & Molecular Biology

SUMO-regulated mitochondrial function in Parkinson's disease

Ana Cristina Guerra de Souza et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Neurosciences

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease

Nour K. Majbour et al.

MOLECULAR NEURODEGENERATION (2016)

Review Behavioral Sciences

Motor symptoms in Parkinson's disease: A unified framework

Ahmed A. Moustafa et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)

Article Cell Biology

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease

Roberto Di Maio et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Multidisciplinary Sciences

Phosphorylation induces distinct alpha-synuclein strain formation

Meng-Rong Ma et al.

SCIENTIFIC REPORTS (2016)

Article Biochemistry & Molecular Biology

Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo

Martial Kamdem Mbefo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

The H50Q Mutation Induces a 10-fold Decrease in the Solubility of α-Synuclein

Riccardo Porcari et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction

Eric S. Luth et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Function and Regulation of the Na + -Ca2+ Exchanger NCX3 Splice Variants in Brain and Skeletal Muscle

Lauriane Y. M. Michel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Evidence of Native α-Synuclein Conformers in the Human Brain

Neal Gould et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity

Ossama Khalaf et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Divergent effects of the H5OQ and G51D SNCA mutations on the aggregation of α-synuclein

Nicola J. Rutherford et al.

JOURNAL OF NEUROCHEMISTRY (2014)

Article Multidisciplinary Sciences

Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour

Giuliana Fusco et al.

NATURE COMMUNICATIONS (2014)

Review Anatomy & Morphology

Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death

Mathieu Bourdenx et al.

FRONTIERS IN NEUROANATOMY (2014)

Review Clinical Neurology

Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials

Lorraine V. Kalia et al.

MOVEMENT DISORDERS (2013)

Review Neurosciences

The many faces of alpha-synuclein: from structure and toxicity to therapeutic target

Hilal A. Lashuel et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Article Multidisciplinary Sciences

Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking

Bong-Kyu Choi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Mutant Protein A30P α-Synuclein Adopts Wild-type Fibril Structure, Despite Slower Fibrillation Kinetics

Luisel R. Lemkau et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Neurosciences

Endoplasmic Reticulum Stress Is Important for the Manifestations of α-Synucleinopathy In Vivo

Emanuela Colla et al.

JOURNAL OF NEUROSCIENCE (2012)

Article Chemistry, Physical

Protein Electrostatic Properties Predefining the Level of Surface Hydrophobicity Change upon Phosphorylation

Anton A. Polyansky et al.

JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2012)

Article Biochemistry & Molecular Biology

Differential Activation of the ER Stress Factor XBP1 by Oligomeric Assemblies

Diana L. Castillo-Carranza et al.

NEUROCHEMICAL RESEARCH (2012)

Article Cell Biology

Sumoylation inhibits α-synuclein aggregation and toxicity

Petranka Krumova et al.

JOURNAL OF CELL BIOLOGY (2011)

Article Neurosciences

Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model

Kang-Woo Lee et al.

JOURNAL OF NEUROSCIENCE (2011)

Article Multidisciplinary Sciences

Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal-lysosomal pathway

George K. Tofaris et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Multidisciplinary Sciences

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

Peter Walter et al.

SCIENCE (2011)

Article Biochemistry & Molecular Biology

Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins

Jobin Varkey et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Chemistry, Medicinal

Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target

Christopher G. Evans et al.

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Neurosciences

ER stress response plays an important role in aggregation of α-synuclein

Peizhou Jiang et al.

MOLECULAR NEURODEGENERATION (2010)

Article Biochemistry & Molecular Biology

Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications

Hong Qing et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Article Biochemistry & Molecular Biology

Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate

Isao Fukuda et al.

CHEMISTRY & BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System

Kelly J. Inglis et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Clinical Neurology

Neuropsychiatric Symptoms in Parkinson's Disease

Dag Aarsland et al.

MOVEMENT DISORDERS (2009)

Review Biochemistry & Molecular Biology

Autophagy in the pathogenesis of disease

Beth Levine et al.

Article Clinical Neurology

Non-motor symptoms in Parkinson's disease

W. Poewe

EUROPEAN JOURNAL OF NEUROLOGY (2008)

Article Biochemistry & Molecular Biology

Monoubiquitylation of α-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells

Ruth Rott et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

The impact of the E46K mutation on the properties of α-synuclein in its monomeric and oligomeric states

Ross A. Fredenburg et al.

BIOCHEMISTRY (2007)

Article Clinical Neurology

Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease

T. Franck et al.

JOURNAL OF NEURAL TRANSMISSION (2006)

Article Biochemistry & Molecular Biology

α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Eirene Kontopoulos et al.

HUMAN MOLECULAR GENETICS (2006)

Article Multidisciplinary Sciences

α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models

Antony A. Cooper et al.

SCIENCE (2006)

Review Biochemistry & Molecular Biology

DNA damage-induced cell death by apoptosis

Wynand P. Roos et al.

TRENDS IN MOLECULAR MEDICINE (2006)

Article Chemistry, Multidisciplinary

Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations

MM Dedmon et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)

Review Chemistry, Multidisciplinary

Protein posttranslational modifications: The chemistry of proteome diversifications

CT Walsh et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)

Article Multidisciplinary Sciences

Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease

E Liani et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Cell Biology

The novel functions of ubiquitination in signaling

LJ Sun et al.

CURRENT OPINION IN CELL BIOLOGY (2004)

Article Biochemistry & Molecular Biology

DJ-1 has a role in antioxidative stress to prevent cell death

T Taira et al.

EMBO REPORTS (2004)

Article Medicine, General & Internal

α-synuclein locus duplication as a cause of familial Parkinson's disease

MC Chartier-Harlin et al.

LANCET (2004)

Article Multidisciplinary Sciences

Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy

AM Cuervo et al.

SCIENCE (2004)

Article Biochemistry & Molecular Biology

Nuclear localization of α-synuclein and its interaction with histones

J Goers et al.

BIOCHEMISTRY (2003)

Review Neurosciences

Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein

J Lotharius et al.

NATURE REVIEWS NEUROSCIENCE (2002)

Article Biochemistry & Molecular Biology

Structural and functional implications of C-terminal regions of α-synuclein

TD Kim et al.

BIOCHEMISTRY (2002)

Article Clinical Neurology

Nonmotor fluctuations in Parkinson's disease -: Frequent and disabling

T Witjas et al.

NEUROLOGY (2002)

Article Cell Biology

α-Synuclein is phosphorylated in synucleinopathy lesions

H Fujiwara et al.

NATURE CELL BIOLOGY (2002)

Review Cell Biology

Sumo, ubiquitin's mysterious cousin

S Müller et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)

Article Biochemistry & Molecular Biology

Synucleins are a novel class of substrates for G protein-coupled receptor kinases

AN Pronin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Article Multidisciplinary Sciences

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy

KA Conway et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)